Tumefactive demyelination: an approach to diagnosis and management
- PMID: 23334629
- DOI: 10.1136/jnnp-2012-304498
Tumefactive demyelination: an approach to diagnosis and management
Abstract
Tumefactive lesions are an uncommon manifestation of demyelinating disease and can pose a diagnostic challenge in patients without a pre-existing diagnosis of multiple sclerosis. Choosing when to biopsy a tumefactive lesion to exclude alternative pathology can be difficult. Other questions include how best to treat an acute attack as well as the optimal timing of therapy to prevent relapse. This article aims to review the available literature for tumefactive demyelination and to propose an approach to diagnosis and management. We argue that disease modifying therapy should be considered for acute tumefactive demyelinating lesions only once criteria of dissemination in time and space are fulfilled and the diagnosis of multiple sclerosis is confirmed.
Keywords: Multiple Sclerosis; Neuroimmunology; Neuropathology; Neuroradiology; Tumours.
Similar articles
-
[Tumefactive Demyelinating Lesions].Brain Nerve. 2024 Aug;76(8):953-960. doi: 10.11477/mf.1416202712. Brain Nerve. 2024. PMID: 39117596 Review. Japanese.
-
Tumefactive demyelinating lesions: A literature review of recent findings.Neurosciences (Riyadh). 2024 Jul;29(3):153-160. doi: 10.17712/nsj.2024.3.20230111. Neurosciences (Riyadh). 2024. PMID: 38981633 Free PMC article. Review.
-
Relapsing Tumefactive Demyelination: A Case Report.Acta Med Acad. 2018 Nov;47(2):193-198. doi: 10.5644/ama2006-124.231. Acta Med Acad. 2018. PMID: 30585071
-
Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.J Child Neurol. 2016 Dec;31(14):1528-1533. doi: 10.1177/0883073816664667. Epub 2016 Aug 29. J Child Neurol. 2016. PMID: 27572815
-
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.Curr Neurol Neurosci Rep. 2016 Mar;16(3):26. doi: 10.1007/s11910-016-0626-9. Curr Neurol Neurosci Rep. 2016. PMID: 26847090 Review.
Cited by
-
Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis.Diagnostics (Basel). 2024 Mar 14;14(6):618. doi: 10.3390/diagnostics14060618. Diagnostics (Basel). 2024. PMID: 38535038 Free PMC article. Review.
-
Therapeutic Plasma Exchange for Treatment-Resistant Tumefactive Demyelinating Lesion: A Case Report.Cureus. 2024 Feb 7;16(2):e53786. doi: 10.7759/cureus.53786. eCollection 2024 Feb. Cureus. 2024. PMID: 38465038 Free PMC article.
-
Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.Sci Rep. 2024 Jan 16;14(1):1426. doi: 10.1038/s41598-024-52048-w. Sci Rep. 2024. PMID: 38228919 Free PMC article.
-
Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis.J Neurol. 2024 Apr;271(4):1663-1667. doi: 10.1007/s00415-023-12164-5. Epub 2023 Dec 28. J Neurol. 2024. PMID: 38153549 No abstract available.
-
A rare case of tumefactive demyelination of brain: A case report and literature review.Clin Case Rep. 2023 Dec 21;11(12):e8369. doi: 10.1002/ccr3.8369. eCollection 2023 Dec. Clin Case Rep. 2023. PMID: 38130854 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources